Results 101 to 110 of about 50,813 (296)

Skin Fragility and Hyperpigmentation in a Patient With HIV

open access: yes
JEADV Clinical Practice, EarlyView.
Catalina Retamal   +2 more
wiley   +1 more source

1726‐nm Laser Treatment of Hidradenitis Suppurativa Tunnels in a Pediatric Skin of Color Patient: Clinical and Ultrasound Outcomes

open access: yesLasers in Surgery and Medicine, EarlyView.
ABSTRACT Objectives To evaluate the safety, tolerability, and early clinical and ultrasound effects of a 1726‐nm laser for hidradenitis suppurativa (HS) tunnels in a pediatric patient with skin of color. Materials and Methods A 16‐year‐old female (Fitzpatrick skin type VI) with moderate HS and bilateral axillary draining tunnels underwent 4 monthly ...
Emilee M. Dreifus   +4 more
wiley   +1 more source

Molecular mechanisms underlying Tao-Hong-Si-Wu decoction treating hyperpigmentation based on network pharmacology, Mendelian randomization analysis, and experimental verification

open access: yesPharmaceutical Biology
Context Hyperpigmentation, a common skin condition marked by excessive melanin production, currently has limited effective treatment options.Objective This study explores the effects of Tao-Hong-Si-Wu decoction (THSWD) on hyperpigmentation and to ...
Jun Chen, Wenyi Ye
doaj   +1 more source

Amiodaroonravi harva esinev kõrvaltoime – naha hüperpigmetatsioon [PDF]

open access: yes, 2003
Naha hüperpigmentatsioonid võivad tekkida erinevatel põhjustel, sealhulgas ka ravimite kõrvaltoimest. Üheks selliseks ravimiks, mis võib põhjustada nahapigmentatsiooni, on laialdaselt kasutatav amiodaroon.
Anijalg, Ene   +3 more
core   +2 more sources

Paediatric Acute Generalised and Localised Exanthematous Pustulosis: A Systematic Review

open access: yes
JEADV Clinical Practice, EarlyView.
Miranda K. Branyiczky   +6 more
wiley   +1 more source

Effectiveness and Safety of Setmelanotide in a Patient With a Heterozygous PCSK1 Deficiency

open access: yesObesity, EarlyView.
ABSTRACT Setmelanotide, a melanocortin 4 receptor (MC4R) agonist, is a promising pharmacological treatment option for people with rare monogenic obesity conditions affecting the leptin‐melanocortin signaling pathway, including proprotein convertase subtilisin/kexin type 1 (PCSK1) gene mutations.
Ellina Lytvyak   +2 more
wiley   +1 more source

Rescue of the MERTK phagocytic defect in a human iPSC disease model using translational read-through inducing drugs. [PDF]

open access: yes, 2017
Inherited retinal dystrophies are an important cause of blindness, for which currently there are no effective treatments. In order to study this heterogeneous group of diseases, adequate disease models are required in order to better understand pathology
Carr, Amanda-Jayne F   +12 more
core   +1 more source

Amyloidosis cutis dyschromica in two female siblings: cases report [PDF]

open access: yes, 2011
Background Cutaneous amyloidosis has been classified into primary cutaneous amyloidosis (PCA, OMIM #105250), secondary cutaneous amyloidosis and systemic cutaneous amyloidosis.
Wenlin Yang   +3 more
core   +1 more source

One‐year follow‐up after fractionated ultra‐high‐dose‐rate FLASH radiotherapy in patient with extramammary Paget disease of the scrotum

open access: yesPrecision Radiation Oncology, EarlyView.
An elderly male patient with extramammary Paget disease of the scrotum and multiple metastases was treated with fractionated FLASH‐RT (40 Gy in 5 fractions) in the scrotal lesion. Abstract Objective Ultrahigh‐dose‐rate radiotherapy (FLASH‐RT) has been shown to reduce radiation‐induced normal tissue injury in preclinical studies.
Hui Luo   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy